FDA Advisory No.2026-0735 || Public Health Warning on the Presence of Sildenafil Citrate in TURBO Maca and Clavo Huasca Dietary Supplement Capsules for Men with Lot Number 24TRB1102 - Food and Drug Administration - fda.gov.ph
FDA Philippines warns against TURBO Maca and Clavo Huasca dietary supplement capsules (Lot 24TRB1102) containing undeclared sildenafil citrate, an erectile dysfunction drug. This is an adulteration issue with serious health risks.
Aforeworn detected this change in the Dietary-Supplement Labeling (FDA) space on July 7, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Critical. Distributors, retailers, and importers of TURBO Maca and Clavo Huasca supplements, especially those handling Lot 24TRB1102. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediate; no grace period.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Dietary-Supplement Labeling (FDA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
FDA issued a public health warning confirming the presence of sildenafil citrate in a specific lot of these supplements, making them adulterated and subject to regulatory action.
Who it affects
Distributors, retailers, and importers of TURBO Maca and Clavo Huasca supplements, especially those handling Lot 24TRB1102.
What you must do
Immediately cease distribution, quarantine all units of Lot 24TRB1102, and notify FDA of inventory and sales. Conduct recall if product has been sold.
Deadline
Immediate; no grace period.
Never miss a change like this again
Aforeworn watches Dietary-Supplement Labeling (FDA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Dietary-Supplement Labeling (FDA)
- FDA Advisory No.2026-0162-A || Lifting the Advisory on the Registered Food Product LUXE SKIN BEAUTY TALKS L’ANNA Premium Oral Sunblock + Stem Cell Dietary Supplement “Public Health Warning Against the Purchase and Consumption of the Unregis - fda.gov.ph
- The Dietary Supplement Industry in the Time of Trump: Potential Opportunities and Pitfalls - Food and Drug Law Institute (FDLI)
- 60 Degrees Pharmaceuticals Signs Exclusive Patent License Agreement with Florida State University for Non-Prescription Use of Australian Chestnut Extract as a Botanical Supplement - GlobeNewswire
- After 4-year review, FDA shuts down attempt to regulate CBD as a supplement and asks Congress for help - AgencyIQ by POLITICO
- US FDA New Dietary Ingredient Notification Submissions in the Last 4 Years - CIRS Group